Zürcher Nachrichten - From Covid to cancer: High hopes for Nobel mRNA vaccines

EUR -
AED 4.049778
AFN 78.834299
ALL 99.033342
AMD 431.456343
ANG 1.973823
AOA 1005.540147
ARS 1184.510488
AUD 1.740106
AWG 1.984619
AZN 1.871047
BAM 1.951157
BBD 2.225918
BDT 133.95119
BGN 1.953417
BHD 0.415629
BIF 3226.660051
BMD 1.102566
BND 1.473074
BOB 7.618042
BRL 6.190801
BSD 1.102437
BTN 94.108603
BWP 15.256919
BYN 3.607729
BYR 21610.297969
BZD 2.214448
CAD 1.554541
CDF 3167.672699
CHF 0.949657
CLF 0.027281
CLP 1046.908381
CNY 8.028391
CNH 8.030442
COP 4581.504452
CRC 555.45727
CUC 1.102566
CUP 29.218005
CVE 110.006211
CZK 25.045922
DJF 195.947771
DKK 7.461959
DOP 69.623267
DZD 146.912551
EGP 55.769964
ERN 16.538493
ETB 145.130438
FJD 2.566609
FKP 0.849767
GBP 0.842206
GEL 3.042781
GGP 0.849767
GHS 17.089472
GIP 0.849767
GMD 78.830087
GNF 9541.515201
GTQ 8.509592
GYD 230.665979
HKD 8.575705
HNL 28.207398
HRK 7.54001
HTG 144.267713
HUF 403.661068
IDR 18465.889357
ILS 4.082247
IMP 0.849767
INR 94.030872
IQD 1444.233926
IRR 46431.844181
ISK 144.314781
JEP 0.849767
JMD 173.672773
JOD 0.781606
JPY 161.04578
KES 142.506807
KGS 95.60528
KHR 4409.646484
KMF 500.014042
KPW 992.369183
KRW 1600.661596
KWD 0.339262
KYD 0.918627
KZT 552.612033
LAK 23885.559894
LBP 98786.765454
LKR 327.39557
LRD 220.466371
LSL 20.781097
LTL 3.255591
LVL 0.666932
LYD 5.33219
MAD 10.487244
MDL 19.686991
MGA 5027.940557
MKD 61.511679
MMK 2314.787019
MNT 3851.769118
MOP 8.833576
MRU 43.813776
MUR 50.023376
MVR 16.990372
MWK 1911.842309
MXN 22.023316
MYR 4.897654
MZN 70.451818
NAD 20.780251
NGN 1695.23982
NIO 40.564638
NOK 11.404074
NPR 150.576289
NZD 1.901293
OMR 0.424466
PAB 1.102556
PEN 4.048086
PGK 4.549174
PHP 62.857624
PKR 309.248804
PLN 4.227851
PYG 8845.546281
QAR 4.019435
RON 4.978193
RSD 117.17297
RUB 92.685108
RWF 1572.964625
SAR 4.136492
SBD 9.180809
SCR 15.773594
SDG 662.092022
SEK 10.787111
SGD 1.473199
SHP 0.866444
SLE 25.171542
SLL 23120.263604
SOS 630.003648
SRD 40.298877
STD 22820.894741
SVC 9.647255
SYP 14336.339478
SZL 20.788701
THB 37.64133
TJS 12.001035
TMT 3.870007
TND 3.373498
TOP 2.582323
TRY 41.871279
TTD 7.474586
TWD 36.451059
TZS 2924.510568
UAH 45.517981
UGX 4017.56488
USD 1.102566
UYU 46.573677
UZS 14239.435486
VES 77.098718
VND 28451.721382
VUV 136.24344
WST 3.123386
XAF 654.272445
XAG 0.034516
XAU 0.000355
XCD 2.97974
XDR 0.825967
XOF 654.373081
XPF 119.331742
YER 270.845622
ZAR 20.688194
ZMK 9924.417531
ZMW 30.622794
ZWL 355.025874
  • RBGPF

    -0.2800

    67.72

    -0.41%

  • RYCEF

    0.0200

    9.8

    +0.2%

  • CMSC

    -0.2240

    22.276

    -1.01%

  • NGG

    3.5900

    69.37

    +5.18%

  • RIO

    -1.4050

    58.495

    -2.4%

  • RELX

    0.5450

    51.525

    +1.06%

  • BCC

    -7.5300

    94.54

    -7.96%

  • VOD

    0.2450

    9.365

    +2.62%

  • BCE

    0.8600

    22.68

    +3.79%

  • SCS

    -0.7400

    10.72

    -6.9%

  • GSK

    1.4050

    39.045

    +3.6%

  • JRI

    -0.2060

    12.834

    -1.61%

  • BTI

    1.7900

    42.04

    +4.26%

  • CMSD

    -0.1600

    22.67

    -0.71%

  • BP

    -2.4750

    31.335

    -7.9%

  • AZN

    1.7110

    73.931

    +2.31%

From Covid to cancer: High hopes for Nobel mRNA vaccines
From Covid to cancer: High hopes for Nobel mRNA vaccines / Photo: Thomas Lohnes - AFP/File

From Covid to cancer: High hopes for Nobel mRNA vaccines

The coronavirus pandemic brought global renown to the mRNA technology that underpins vaccines from Pfizer/BioNTech and Moderna, and on Monday earned a Nobel Prize for two scientists who have been key to its development.

Text size:

Katalin Kariko of Hungary and Drew Weissman of the United States won the Nobel Medicine Prize for their work on "nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19".

These types of jabs are new but researchers have been working for decades to try to figure out how to use messenger RNA (ribonucleic acid) for other vaccinations and to treat illnesses from AIDS to cancer.

- How does it work? -

Messenger RNA's job in the body is to help deliver specific instructions from DNA to cells.

In the case of the Pfizer/BioNTech and Moderna jabs, lab-generated mRNA tells human cells to create antigens -- proteins that are similar to ones found in the Covid-19 virus.

Thanks to those antigens, a person's immune system learns how to fight the virus and neutralise Covid if it enters the body.

After the cells create these proteins, the body breaks down the mRNA instructions and gets rid of them.

Such direct communication with cells is revolutionary -- classic vaccines aimed to provoke an immune response by injecting a neutralised form of a virus or antigens into the system.

- Where did this come from? -

The first big breakthrough, in the late 1970s, was in using mRNA to make test-tube cells produce proteins.

A decade later, scientists were able to get the same results in mice, but mRNA still had two major drawbacks as a medical tool.

For one thing, cells in live animals resisted synthetic mRNA, provoking a dangerous immune response.

On top of that, mRNA molecules are fragile, making them difficult to deliver to the system without altering them.

In 2005, Kariko and Weissman of Penn State University published a groundbreaking study showing that a lipid -- or fat molecule -- envelope could safely deliver mRNA without negative effects.

The research caused a buzz in the pharmaceutical community and start-ups dedicated to mRNA therapies began to pop up around the world.

- What else can mRNA do? -

Scientists have worked on developing mRNA jabs for illnesses like seasonal flu, rabies and Zika, as well as those that have remained vaccine-resistant until now, including malaria and AIDS.

Researchers have also started testing personalised treatments on cancer patients, using samples of the proteins in their tumours to create specialised mRNA.

This then triggers the immune system to target specific cancer cells.

"The mRNA platform is versatile," University of Pennsylvania biochemist Norbert Pardi told AFP. "Any protein can be encoded as mRNA so there are many potential applications."

O.Pereira--NZN